Predicting disease severity in children with combined attention deficit hyperactivity disorder using quantitative

Shanghu Song1,2, Jianfeng Qiu1,2, Weizhao Lu1,2,3

  • 1Medical Engineering and Technology Research Center, Shandong First Medical University and Shandong Academy of Medical Sciences, Tai'an, People's Republic of China.

Insights

Brain imaging of the amygdala and hippocampus can predict attention deficit hyperactivity disorder (ADHD) severity in children. This study used MRI data to identify volumetric features linked to ADHD-C, offering potential biomarkers for disease evaluation.

Area of Science:

  • Neuroscience
  • Radiology
  • Psychiatry

Background:

  • Children with combined attention deficit hyperactivity disorder (ADHD-C) exhibit volumetric alterations in amygdaloid and hippocampal subfields.
  • Understanding these structural changes is crucial for predicting disease severity.

Purpose of the Study:

  • To investigate the predictive capability of amygdaloid and hippocampal subfield volumetric changes for disease severity in children with ADHD-C.
  • To identify specific subregions within the amygdala and hippocampus associated with ADHD severity.

Main Methods:

  • Utilized T1 structural MRI data from 76 ADHD-C patients from the ADHD-200 datasets.
  • Extracted 64 structural features from the amygdala and hippocampus.
  • Employed Sequential Backward Elimination (SBE) for feature selection and a linear Support Vector Regression (SVR) model to predict ADHD severity using three ADHD rating scales.

Main Results:

  • The SBE-SVR model accurately predicted ADHD severity, achieving a high correlation (0.7164, p<0.001) for the ADHD index.
  • Identified specific amygdaloid and hippocampal subregions significantly related to ADHD severity based on SVR model weights.
  • The model demonstrated a mean squared error of 43.6868 and mean absolute error of 3.2893.

Conclusions:

  • The SBE-SVR approach effectively predicts ADHD-C severity using quantitative MRI-based features from the amygdala and hippocampus.
  • These subcortical structures show potential as biomarkers for monitoring ADHD progression and evaluating treatment effectiveness.